Trip.com Group Limited (TCOM) — a leading China-based online travel platform whose American Depositary Receipts (ADRs) trade on the Nasdaq — has been one of the most watched travel stocks of the past year. After peaking near $79 in early 2026, the shares fell sharply and now hover in the mid-$40s. That decline has left investors asking a straightforward question: can TCOM recover and reach the widely cited $60 stock price target?
Trip.com Group operates a portfolio of travel brands including Ctrip, Qunar, Trip.com, and Skyscanner, spanning hotel bookings, air tickets, packaged tours, and corporate travel. It holds a dominant position in China's online travel market and has been expanding aggressively into Asia-Pacific, Europe, and the Middle East.
The $60 level matters because it sits squarely at the center of the analyst consensus. According to data from Investing.com and Finviz, the average 12-month price target for TCOM is roughly $60, with individual estimates ranging from the low $40s to the high $80s. Because $60 also represents a clean round-number milestone roughly halfway back toward the stock's recent high, it has become a focal point for investors searching for a realistic recovery scenario.
TCOM closed at $46.11, with its 52-week range spanning approximately $38 to $79. The shares are down more than 30% year-to-date and nearly 30% over the trailing 12 months, reflecting a meaningful de-rating rather than a broken business. Despite the decline, the company trades at a trailing P/E ratio of roughly 7, with a market capitalization near $30 billion, substantial cash and short-term investments, and a modest dividend.
The catalyst for the sell-off was the SAMR antitrust investigation disclosed in January 2026. The probe, which reportedly centers on automatic repricing and potential "price parity" behavior in hotel distribution, introduced significant regulatory uncertainty even though the company's underlying financial momentum has remained strong.
Several factors support a move toward $60. First, travel demand in China has stayed resilient, with outbound hotel and air ticket volume growing strongly during peak holiday periods. Second, the company's international Trip.com brand has been a standout, with overseas revenue growth far outpacing the domestic business as it gains share in new regions. Third, the valuation is undemanding relative to earnings power — a trailing P/E near 7 leaves room for multiple expansion if regulatory fears ease.
Fundamentally, Trip.com reported rising revenue and healthy adjusted margins in recent quarters, aided by inbound travel and visa-waiver policies that are expanding the overall Chinese travel market. A favorable resolution, or even a benign outcome, from the antitrust probe could remove the primary overhang on sentiment.
The most immediate obstacle is regulatory risk. The SAMR investigation could result in fines, compliance requirements, or operational changes, and uncertainty is likely to persist for months. Broader Chinese macro weakness and soft consumer spending also pose risks to travel demand, while ADR-specific and geopolitical considerations can add volatility to U.S.-listed Chinese equities.
Additionally, the rapid expansion of the lower-margin overseas business may dilute group profitability in the near term, even as it builds long-term scale. Analysts at JPMorgan have noted that while the stock looks undervalued, consensus estimates may not yet fully reflect the possibility that management suppresses earnings during the investigation period.
Wall Street remains broadly constructive. The consensus rating is "Strong Buy," with the large majority of covering analysts recommending the stock as a Buy. Recent actions illustrate the range of views: JPMorgan maintains an Overweight rating with a $72 target, BofA holds a Buy rating with a $64 target, and Citigroup maintains coverage near $62, while Morgan Stanley, Barclays, and Benchmark have targets of $70 to $75. At the cautious end, China Renaissance downgraded the shares to Hold with a $42 target.
In aggregate, these figures place the consensus average near the $60 level that frames the central question. Notably, even the more conservative published targets sit close to or above the current price, suggesting limited downside is priced into many estimates.
From a technical analysis perspective, the 52-week low near $38 represents the most important support level, while the prior peak near $79 marks the recovery ceiling. The $50 round number is the first significant psychological resistance, and clearing it would help confirm that a trend reversal is underway. The $60 area aligns with both the analyst consensus and a historical supply zone, meaning any push toward that target would need to be accompanied by improving sentiment and rising demand for the shares.
For traders monitoring whether TCOM can reclaim the $60 level, tracking shifting market conditions in real time can be valuable. Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on evolving market conditions, technical behavior, and AI-driven analysis. The tool is designed to help traders spot opportunities, monitor existing positions, and identify changing market trends more efficiently than manual screening. Investors watching TCOM's recovery can explore these signals to stay informed as conditions develop.
A move to $60 appears realistic but is not guaranteed. The strongest arguments in its favor are a dominant market position, resilient travel demand, rapid international growth, a low valuation, and a "Strong Buy" consensus whose average target already sits at that level. The primary obstacles are the unresolved antitrust investigation, softer Chinese macro conditions, and near-term margin pressure from overseas expansion.
Investors should monitor the outcome of the SAMR probe, quarterly travel volume and margin trends, and whether the stock can hold support near $38 while building momentum through the $50 resistance level. Reaching $60 would most likely require a combination of regulatory clarity, sustained earnings growth, and a re-rating of the shares toward their historical valuation.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor tells us that TCOM and ABNB have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TCOM and ABNB's prices will move in lockstep.
| Ticker / NAME | Correlation To TCOM | 1D Price Change % | ||
|---|---|---|---|---|
| TCOM | 100% | -5.11% | ||
| ABNB - TCOM | 29% Poorly correlated | +1.09% | ||
| NCLH - TCOM | 25% Poorly correlated | +0.13% | ||
| BKNG - TCOM | 25% Poorly correlated | -2.24% | ||
| EXPE - TCOM | 24% Poorly correlated | -1.60% | ||
| SCI - TCOM | 23% Poorly correlated | +2.08% | ||
More | ||||
| Ticker / NAME | Correlation To TCOM | 1D Price Change % |
|---|---|---|
| TCOM | 100% | -5.11% |
| Consumer Sundries industry (19 stocks) | 36% Loosely correlated | -0.76% |
| Consumer Non Durables industry (183 stocks) | -1% Poorly correlated | -0.31% |